Literature DB >> 19488760

Factors predicting inguinal node metastasis in squamous cell cancer of penis.

Suresh K Bhagat1, Ganesh Gopalakrishnan, Nitin S Kekre, Ninan K Chacko, Santosh Kumar, M T Manipadam, Prasanna Samuel.   

Abstract

PURPOSE: To identify factors predicting the risk of inguinal metastasis in squamous cell carcinoma of the penis. The therapeutic advantages of early lymphadenectomy in squamous cell carcinoma of the penis must be counterbalanced against its post-operative morbidity. Loss to follow up is a major problem in developing countries. Generating a nomogram based on clinical lymph node status and histopathological findings in the primary tumor could facilitate clinical decision making in the management of penile cancer.
METHODS: We prospectively studied 106 patients with penile squamous cell cancer treated from September 2001 to August 2007 at our institution. All patients were offered lymphadenectomy (LAD). A multivariate logistic regression model was used to develop a nomogram. We highlight the problems of loss to follow up in these patients.
RESULTS: Of 53 who opted for LAD, 22 had nodal metastasis. The presence of high grade (P = 0.004), lymphovascular invasion (LVI) (P = 0.01) and palpable inguinal lymph nodes (P = 0.05) were the strongest predictors of metastasis. Of 51 who refused LAD, 22 were lost to follow up. Out of these, 16 were at high risk and 9 of them came back with inoperable fungating nodes. A nomogram predicting the risk of lymph node metastasis showed a bias corrected good concordance index (0.74) and good calibration.
CONCLUSIONS: High grade and LVI in the tumor along with clinical stage of the inguinal nodes were the strongest predictors of metastasis. These features helped us to develop a nomogram to predict and to identify patients at risk of nodal metastasis.

Entities:  

Mesh:

Year:  2009        PMID: 19488760     DOI: 10.1007/s00345-009-0421-1

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  17 in total

Review 1.  Lymphadenectomy for squamous cell carcinoma of the penis. Part 2: the role and technique of lymph node dissection.

Authors:  S Horenblas
Journal:  BJU Int       Date:  2001-09       Impact factor: 5.588

2.  EPIDERMOID CARCINOMA OF THE PENIS.

Authors:  J H BEGGS; J S SPRATT
Journal:  J Urol       Date:  1964-02       Impact factor: 7.450

3.  Nomogram predictive of pathological inguinal lymph node involvement in patients with squamous cell carcinoma of the penis.

Authors:  Vincenzo Ficarra; Filiberto Zattoni; Walter Artibani; Andrea Fandella; Guido Martignoni; Giacomo Novara; Tommaso Prayer Galetti; Tiziano Zambolin; Michael W Kattan
Journal:  J Urol       Date:  2006-05       Impact factor: 7.450

4.  Prognostic factors in carcinoma of the penis: multivariate analysis of 145 patients treated with amputation and lymphadenectomy.

Authors:  A Lopes; G S Hidalgo; L P Kowalski; H Torloni; B M Rossi; F P Fonseca
Journal:  J Urol       Date:  1996-11       Impact factor: 7.450

5.  Management of clinically node negative penile carcinoma: improved survival after the introduction of dynamic sentinel node biopsy.

Authors:  A P Lont; S Horenblas; P J Tanis; M P Gallee; H van Tinteren; O E Nieweg
Journal:  J Urol       Date:  2003-09       Impact factor: 7.450

6.  Outcomes of initial surveillance of invasive squamous cell carcinoma of the penis and negative nodes.

Authors:  D Theodorescu; P Russo; Z F Zhang; C Morash; W R Fair
Journal:  J Urol       Date:  1996-05       Impact factor: 7.450

7.  Squamous cell carcinoma of the penis. III. Treatment of regional lymph nodes.

Authors:  S Horenblas; H van Tinteren; J F Delemarre; L M Moonen; V Lustig; E W van Waardenburg
Journal:  J Urol       Date:  1993-03       Impact factor: 7.450

8.  EAU Guidelines on Penile Cancer.

Authors:  E Solsona; F Algaba; S Horenblas; G Pizzocaro; T Windahl
Journal:  Eur Urol       Date:  2004-07       Impact factor: 20.096

9.  Carcinoma of the penis: improved survival by early regional lymphadenectomy based on the histological grade and depth of invasion of the primary lesion.

Authors:  W S McDougal
Journal:  J Urol       Date:  1995-10       Impact factor: 7.450

10.  Penile cancer: relation of extent of nodal metastasis to survival.

Authors:  V Srinivas; M J Morse; H W Herr; P C Sogani; W F Whitmore
Journal:  J Urol       Date:  1987-05       Impact factor: 7.450

View more
  6 in total

1.  Prognostic factors in patients with penile cancer after surgical management.

Authors:  Shuguang Wen; Wenbiao Ren; Bichen Xue; Yi Fan; Yongjun Jiang; Chunming Zeng; Yujia Li; Xiongbing Zu
Journal:  World J Urol       Date:  2018-01-03       Impact factor: 4.226

2.  Prognostic value of CD44 expression in penile squamous cell carcinoma: a pilot study.

Authors:  Daniele Minardi; Guendalina Lucarini; Alessandra Filosa; Antonio Zizzi; Oriana Simonetti; Anna Maria Offidani; Gianluca d'Anzeo; Roberto Di Primio; Rodolfo Montironi; Giovanni Muzzonigro
Journal:  Cell Oncol (Dordr)       Date:  2012-09-13       Impact factor: 6.730

3.  Nomograms to predict the presence and extent of inguinal lymph node metastasis in penile cancer patients with clinically positive lymph nodes.

Authors:  Xiang Zhou; Yan Zhong; Lebin Song; Yamin Wang; Yichun Wang; Qijie Zhang; Rong Cong; Chengjian Ji; Tongfu Yu; Ninghong Song
Journal:  Transl Androl Urol       Date:  2020-04

4.  Analysis of the related risk factors of inguinal lymph node metastasis in patients with penile cancer: A cross-sectional study.

Authors:  Yatao Jia; Hongwei Zhao; Yun Hao; Jiang Zhu; Yingyi Li; Yanbo Wang
Journal:  Int Braz J Urol       Date:  2022 Mar-Apr       Impact factor: 1.541

5.  Warty carcinoma of the penis: A clinicopathological study from South India.

Authors:  Marie Therese Manipadam; Suresh Kumar Bhagat; Ganesh Gopalakrishnan; Nitin S Kekre; Ninan K Chacko; Samuel Prasanna
Journal:  Indian J Urol       Date:  2013-10

6.  Predictors of inguinal lymph node metastasis in penile cancer patients: a meta-analysis of retrospective studies.

Authors:  Jiao Hu; Yu Cui; Peihua Liu; Xu Zhou; Wenbiao Ren; Jinbo Chen; Xiongbing Zu
Journal:  Cancer Manag Res       Date:  2019-07-10       Impact factor: 3.989

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.